Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner

U Ikeda1, M Ikeda, T Oohara

  • 1Department of Cardiology, Jichi Medical School, Tochigi, Japan.

Insights

Interleukin 6 (IL-6) promotes vascular smooth muscle cell (VSMC) growth by stimulating endogenous platelet-derived growth factor (PDGF) production. This autocrine signaling pathway enhances VSMC proliferation.

Area of Science:

  • Cardiovascular Biology
  • Cellular Signaling
  • Molecular Medicine

Background:

  • Vascular smooth muscle cell (VSMC) proliferation is a key factor in cardiovascular diseases.
  • Interleukin 6 (IL-6) is a cytokine with known roles in inflammation and cell growth.
  • The specific mechanisms by which IL-6 influences VSMC growth require further elucidation.

Purpose of the Study:

  • To investigate the effect of IL-6 on the proliferation of rat aortic VSMC.
  • To determine the signaling pathways involved in IL-6-mediated VSMC growth.
  • To explore the potential autocrine role of IL-6 in VSMC biology.

Main Methods:

  • Isolation and culture of rat aortic VSMC.
  • Assessment of VSMC proliferation using [3H]-thymidine incorporation.
  • Measurement of intracellular calcium ([Ca2+]i) levels.
  • Analysis of IL-6 and PDGF mRNA and protein expression.
  • Inhibition studies using verapamil (Ca2+ channel blocker) and anti-PDGF antibody.

Main Results:

  • Murine recombinant IL-6 significantly increased VSMC number and thymidine incorporation in a dose-dependent manner.
  • IL-6-induced proliferation was inhibited by anti-PDGF antibody but not by verapamil.
  • IL-6 did not affect basal intracellular calcium levels, whereas PDGF increased [Ca2+]i.
  • IL-6 treatment stimulated PDGF production in VSMC.
  • IL-6 mRNA expression was induced by fetal bovine serum.

Conclusions:

  • IL-6 promotes VSMC growth through the induction of endogenous PDGF production.
  • This suggests an autocrine signaling loop where IL-6 stimulates its own release and subsequent VSMC proliferation.
  • The findings highlight IL-6 and PDGF as potential therapeutic targets in cardiovascular conditions characterized by VSMC hyperplasia.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...